Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

BACKGROUND: Anti-PD-1 therapy is increasingly used in various advanced malignancies. Patients with baseline organ dysfunction are largely excluded from clinical trials. Therefore it is unclear whether anti-PD-1 therapy is safe or effective in this setting. Further, these patients are often not candi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanz, Bridgette A., Pollack, Megan H., Johnpulle, Romany, Puzanov, Igor, Horn, Leora, Morgans, Alicia, Sosman, Jeffrey A., Rapisuwon, Suthee, Conry, R. Martin, Eroglu, Zeynep, Johnson, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067899/
https://www.ncbi.nlm.nih.gov/pubmed/27777770
http://dx.doi.org/10.1186/s40425-016-0166-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067899/
https://www.ncbi.nlm.nih.gov/pubmed/27777770
http://dx.doi.org/10.1186/s40425-016-0166-5

Ejemplares similares